Summary Six human cancer cell lines exhibiting a large range of sensitivity to 5-fluorouracil (5-FU) were evaluated for thymidylate synthase (TS) and p53 gene expression, TS and dihydropyrimidine dehydrogenase (DPD) activity, as well as cell cycle parameters, S-phase fraction (SPF), bromodeoxyuridine labelling index (LI) and S-phase duration (SPD). All None of the cell lines had previously been exposed to 5-FU. and thus exhibited spontaneous difference in sensitivity to 5-FU.
Thymidylate synthase (TS) catalyses the reductive methylation of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP) using 5.10-methylene-tetrahydrofolate (5. 10-CH,FH4) as a methyl donor co-substrate. This reaction is an essential step in DNA biosynthesis. as it provides the only de novo source of dTMP. Another way is the thymidine salvage pathway. which can produce dTMP from thymidine by thymidine kinase (TK) action. TS is a critical target for fluoropyrimidine drugs widely used in cancer treatment. either alone or as radiation sensitizers. The metabolization of 5-fluorouracil (5-FU) in cancer cells results in 5-fluorodeoxyuridine monophosphate (FdUMP) synthesis. w%hich inhibits DNA synthesis by TS blocking through a tight covalent ternary complex with TS. 5,1 O-CH,FH4 and FdUMP.
Other 5-FU metabolites are incorporated into DNA and RNA.
Different mechanisms of 5-FU resistance have been described.
Althougrh each of these mechanisms has been documented in both in vitro and in viv-o model systems. their relative contribution to the development of clinical drug resistance remains uncertain. However, there is a growing body of evidence to suggest that resistance to the cytotoxic effects of the fluoropyrimidines as manifested in patient tumour specimens may be mediated via a TS-directed process. Specifically. two mechanisms have been identified that may have direct clinical relevance, and include a relative deficiency in intracellular folates resulting in decreased inhibition of TS activity and/or increased expression of TS.
Several mechanisms have been described that can account for modification in the activity of TS. Previous studies have demonstrated that TS activity is higher during DNA replication and activity and TS gene expression are poorly understood. Even if TS activity can be associated with proliferation. its regulation may be independent of DNA synthesis and cell cycle phase (Jenh et al. 1985) . Recently. Pestalozzi et al (1995) showed that TS protein levels are directly associated with S-phase in asynchronously growinc neoplastic cells. but. surprisingly. no increase in TS expression was detected in the S-phase population of asvnchronous cells.
The first purpose of this study was to analyse TS gene expression and enzyme activity in relation to the S-phase fraction in six human cancer cell lines growing asynchronously according to their respective sensitivity to 5-FU. Moreover. as we previously demonstrated that cell lines with a shorter doubling time exhibited significantly higher sensitivity to 5-FU (Mirjolet et al. 1997) . cell cycle kinetic parameters (labelling index and S-phase duration) were evaluated using flow cytometry. The investigated cell lines were representative of squamous cell carcinoma of the upper aerodigestive tract treated by concomitant radio-chemotherapy and also corresponded to the spectrum of human malignancies treated by 5-FU. i.e. digestive tract. breast. and head and neck cancers.
None of the cell lines had previously been exposed to 5-FU. and thus exhibited spontaneous difference in sensitivity to 5-FU. (Labsystem, Cergy-Pontoise, France) . Results were expressed as relative absorbance to untreated controls. 5-FU concentrations yielding 50% growth inhibition (ICy) were calculated using medium-effect algorithm (Chou and Talalay, 1987) 5,10-methylene-5,6,7,8-tetrahydrofolate (0. 63 mm final concentration) in a total volume of 55 jl in Tris HCG buffer. After 0, 5, 10, 15, 20 and 25 min of incubation at 37°C, the reaction was stopped on ice.
MtATERIALS AND METHODS

Materials and chemicals
Excess of [3H]dUMP was removed by adding 300 l of activated charcoal (15%) containing 4% trichloroacetic acid (5 min centrifugation at 140000g, room temperature). Tritiated water formed during the incubation was then quantified by liquid scintillation (Beckman LS1800, Gagny, France). Cytosolic proteins were quantified according to the bicinchoninic assay (Smith et al, 1985) using bovine serum albumin as standard. Results were expressed as fmol of 3H,O formed per min per mg of protein. Each experiment was performed in triplicate and TS activity determinations were at least triplicated (three independent expeiments).
Dihydropyrimidine dehydrogenase (DPD) activity DPD activity was measured according to the method described by Harris et al (1990) . Cell suspensions (5.106 to 10.106 cells ml-') were prepared in 35 mm sodium phosphate buffer, pH 7.5. containing 10% glycerol. The cell suspensions were then centrifuged (5 min, 250g) and the cell pellets were stored at 400C without impairment of DPD activity. On the day of the assay, the cell suspension was freeze-thawed three times and centrifuged for 30 min at 28 000 g (4°C). Supernatants were kept on ice until assayed within 15 min. The (1998) 78(1), [62] [63] [64] [65] [66] [67] [68] (-) . FaDu, according to the method reported by Begg et al (1992) .
nt the means ± s.d. of of each 5'-and 3'-primers. and finally 0.5 units of Taq polymerase. The primer sequences were as follows: TS 1. 5'-GGCAGATC-CAACACATCCTCCGCT-3' (sense); TS2. 5'-CCAGAACACACGTlTTGGTTGTCAG-3' (antisense) (Takeishi et al, 1985) : pS3a. 1 min at 57'C and 1 min at 72'C for one cycle and the following 33 cycles were 1 min at 94'C. 1 min at 57'C and 1 min at 72'C. In each case, after completion of PCR cycles. the mixture was finally incubated for 7 min at 72'C.
Statistical analysis
Unless otherwise indicated. all data are mean values ± s.d. calculated from at least three independent expenrments. Speannan's rank correlation was used to test the correlation between the different parameters.
RESULTS 5-FU sensitivity, TS and DPD activities (Table 1)   Table 1 shows 5-FU sensitivity and enzyme activities for the whole cell line panel. Enzyme activities were measured before or during exponential growing phases respectively for TS and DPD. Enzyme activities were measurable in all cell lines and varied within a 12-and 5-fold range for TS and DPD respectively. Cell lines displayed marked differences in 5-FU sensitivity, with IC 0 values ranging from 62 (CAL51) to 3217 jiM (PANC3). Cell doubling times ranged from 18 (CAL51) to 33h (PANC3). with cells seeded at equivalent density (10' cells ml-'). Doubling times (DT) and 5-FU ICS. were statistically correlated (r = 0.786. P = 0.008). These British Joumal of Cancer (1998) experiments clearly showed that cells with high 5-FU sensitivity displayed shorter DT and. conversely, cells with low sensitivity displayed the longer DT. This parallel evolution of 5-FU sensitivity with DT in these six cancer cell lines led us to investigate the relationship between cell proliferation parameters and 5-FU cytotoxicity. Moreover, no significant correlation was observed between TS or DPD activities and 5-FU sensitivity in any of the six cell lines whenever the cells were taken before, during and after their exponential growing phase.
Enzyme activities and genes expression TS activity and gene expression were evaluated 72, 120 and 168 h after plating and were significantly correlated with time (Figures 1  and 2 ). For nearly all cell lines, TS catalytic activity reached a maximum at 72 or 120 h after plating (Figure 3) . Maximum TS gene expression was reached at 72 h in each case and then deceased regularly from day 3 to day 7 (Figure 2 ). For all cell lines, these maxima appeared simultaneously with the highest S-phase fraction (Figure 3) . Suprisingly. the CAL5 1 cell line displayed the highest TS expression (34.0 ± 2.4. Table 2 ) but a relatively low activity (3.5 ± 0.2 fmol min-' mgo-TS). Conversely. the PANC3 cell line, which showed the highest TS activity (7.4 ± 0.3 fmol mM mg'), presented a low TS expression (10.3 ± 1.0). p53 expression ranged from 0.06 (PANC3) to 2.58 (CAL5 1) in 5-FU-free cultured cells (Table 2 ). The CAL51 cell line displayed the highest TS expression (34.0 ± 2.4, Table 3 ) and also the highest p53 expression (2.54 ± 0.16. Table 2 ).
Dihydropyrimidine dehydrogenase activity DPD catalytic activity was measured in exponentially growing cells (day 5). Results are presented in Table 1 and show a higher DPD activity for the CAL5 1 cell line (42 ± 6 fmol min-' mg-'). No significant specific correlation was observed between DPD and TS catalytic activity or between DPD activity and 5-HU sensitivity.
Cell cycle analysis
Using flow cytometry. no difference was observed between Sphase fractions determined with PI or BrdUrd incorporation (data not shown).
Changes in TS activities and gene expression were associated with variations in the distribution of cells in the cell cycle ( Figure  3 ). Figure 3 shows that the S-phase fraction was maximum at 72 h for CAL33. FaDu and PANC3 cell lines and at 120 h for CAL27. CAL51 and KB cell lines. S-phase fraction was minimal when cells reached confluence (168 h). 14% to 40% for FaDu and CAL5 1 respectively. TS activity was higher in proliferating cells (72 or 120 h) than in non-proliferating cells (Figure 3 ). Nevertheless. TS activity was not significantly higher in rapidly growing cell lines with short doubling time (Table 1) .
5-FU sensitivity and proliferation
Asynchronous cells were analysed by double labelling flow cytometry for BrdUrd and DNA content at various time points. BrdUrd was measured as FITC fluorescence intensity (Table 2) and DNA content as propidium iodide fluorescence intensity. The results of labelling index (LI) and S-phase duration (SPD) obtained for the six cell lines were correlated with 5-FU sensitivity (Tables 3 and 4 ). The evolution of 5-FU sensitivity showed statistically significant correlations with the LI corresponding values; P = 0.0007, 0.0053 and 0.0665 respectively for cells taken before (72 h). during (120 h) and after cells' exponential growth phase (168 h. Table 4 ). When determined in parallel with TS activity and gene expression, no significant correlation was found between LI and/or SPD and TS activity or gene expression.
DISCUSSION
Previous studies (Conrad. 1971 ) demonstrated a relationship between S-phase and TS protein levels and suggested that TS would be an S-phase specific enzyme. According to our results.
TS activity was associated with variations in the distribution of cells throughout the cell cycle and was found to be higher in proliferating cells (Figure 3 ). However, no statistically significant correlation was observed. lead to a closer correlation between the activity of this S-phase specific enzyme and cell cycle variation (Matherly et al, 1989) . This point was interpreted in terms of stuctural interactions between proteins within a multienzyme complex, which was called replitase and which was hypothesized as being responsible for DNA replication (Plucinski et al, 1990) . If regulation mechanisms are considered, a lack of association between cell cycle and TS activity could have several explanations (Cadman and Heimer, 1986) . In keeping with its central role in cell growth, the TS activity is under tight control in the cell and regulated at multiple levels. For all six cell lines, TS gene expression decreases only within a narrow range as expressed by the following equation y = -1.848 (±1.506)x + 19.91 (±13.88) (Figure 1) . When considering the decrease in gene expression through cell proliferation, the ratio of TS expression between 120 and 168 h varied approximately 1.3±0.09. Our data are consistent with those of Ali Imam et al (1987) , who demonstua that amplification of the TS gene does not alter its tempoal expression and, moreover, clearly showed that the TS gene is not responsible for overproduction of TS enzyme and for consequent resistance to 5-FU (Table 1 ). In the PANC3 cell line, experiments showed that high TS activity can be associated with low TS expression, also indicating a post-translational control (Chu et al, 1990 ).
Overproduction of TS arising from a corresponding increase in TS mRNA and in the number of copies of the TS gene (Jenh et al, 1985) has been observed with a variety of cherotherapeutic drugs British Jumxal of Cancer (1998) (Schimke, 1984) . In addition, acute exposure of cells to TS inhibitors such as fluorinated pyrimidines or folate analogues also leads to a rapid increase in T'S enzyme levels, and the biochemical basis for this rapid increase is unlikely to be caused by gene amplification (Chu et al, 1991a (Kaneda et al, 1987) . Assuming that the elongation rate is normal, this would lead to a small number of ribosomes per TS mRNA and a relatively large fraction of TS mRNA that is not associated with ribosomes (Kaneda et al, 1987) . These observations raised the hypothesis that human TS enzyme regulates the translation of its own mRNA. In CAL5 1 line, a relatively low TS activity (2.3 fmol min-' mg-' protein) can be associated with a high TS expression (34.0 ± 2.4).
TS and p53 are two proteins critically involved in DNA biosynthesis, cellular growth and proliferation. As the expression of each of these proteins is controlled, in part by a translational regulatory process, Chu and Allegra (1996) determined whether the expression of p53 could be regulated by T'S using an immunoprecipitation RT-PCR method. Their experiments demonstrated that binding of 1'S to p53 mRNA results in translational repression.
Although the actual mechanism by which TS represses p53 mRNA translation remains to be characterized, these preliminary studies suggest that TS specially inhibits translational initiation. According to p53 gene expression results (Table 2) , the cell line displaying the highest TS gene expression (CAL51) also showed the highest p53 gene expression (Table 2) , but a low TS activity (Table 1 ). The excess of p53 expression may then be able to bind to and to sequester free TS protein, and, consequently, may inhibit both catalytic activity and RNA binding functions (Chu and Allegra, 1996) . In order to assess the binding between TS protein and p53 mRNA, these observations should be confimed by gelshift experiments.
No correlation between 5-FU sensitivity and TS gene expression or activity was evidenced, which clearly shows that these two parameters cannot predict sensitivity or resistance to 5-FU (Table 1) . Several cellular and molecular factors related to metabolism and disposition of 5-FU lead to alterations in tumour tissue sensitivity (Barberi Heyob et al, 1995; Fety et al, 1997) . 5-FU transport deficiency has not been reported to be associated with resistance, but aberrations in its metabolism to FdUMP (the inhibitor of TS) or to FUTP (the metabolite for RNA incorporation) have been associated with resistance (Peters and Van Groeningen, 1991) . In a panel of 19 cell lines from various histological origins, Beck et al (1994) reported that 5-FU sensitivity and TS activity were related despite a poor significance (r2 = 0.22). Like Peters et al (1994), we did not observe any significant relationship, suggesting that sensitivity was mainly related to a balance in the activities of anabolic and catabolic enzymes, as already proposed in other studies (Evans et al, 1980 , Fmdlay et al, 1997 . According to our results (Table 1) this point cannot explain the poor relationship observed between 5-FU sensitivity and TS activity or expression as DPD activity was also determined (Table 1) . Moreover, we did not observe any significant relationship (P = 0.49) between TS and DPD activity. These data suggest that additional factors may play a role in 5-FU sensitivity, although TS and/or TK seem to be mainly implicate On the other hand, our results show that S-phase duration and cell proliferaton (BrdUrd incorporation) could be informative for 5-FU cytotoxicity (Table 4 ). At present, the best predictive factor for cellular cytotoxicity seems to be the cell proliferation based on in vitro BrdUrd infusion and analysis of cell labelling index (LI) by flow cytometry. Tberefore, flow cytometry analysis could be especially informative in determining the doubling time of umour tissue and would therefore allow a logical choice for either a biochemical modulation thrapy or a conconitant radio-chenmoherapy. In addition, as LI can also be used for radiotapy tratment planning by evaluation of cell labelling by flow cytometiy (Riccardi et al, 1988; Marchal et al, 1997) this parameter should be especially relevant in case of concomitant radio-chemotrapy.
